Prevention of febrile neutropenia in oncological patients: real-world data
Aim. To assess the effect of febrile neutropenia (FN) prophylaxis with granulocyte colony-stimulating factors (G-CSF) in real-world cancer patients. Materials and methods. We conducted a statistical analysis of anonymized medical records collected in the Webiomed platform. Before analysis, the ca...
Main Authors: | Kirill V. Sapozhnikov, Irina V. Sorokina, Aleksandr V. Gusev, Natalia A. Sableva, Valeriia D. Sokolova, Daria G. Tolkacheva, Anna M. Berezina |
---|---|
Format: | Article |
Language: | Russian |
Published: |
IP Habib O.N.
2023-05-01
|
Series: | Современная онкология |
Subjects: | |
Online Access: | https://modernonco.orscience.ru/1815-1434/article/viewFile/430284/124927 |
Similar Items
-
How I treat febrile neutropenia
by: Marcio Nucci
Published: (2021-02-01) -
Optimizing Empiric Vancomycin Use in Febrile Neutropenia Patients
by: Nicole Tadros, et al.
Published: (2021-12-01) -
Clinical Epidemiology Characteristics and Etiology of Febrile Neutropenia in Children: Analysis of 421 Cases
by: Sang Ngoc Nguyen, et al.
Published: (2022-08-01) -
Continuous Intravenous Administration of Granulocyte-Colony-Stimulating Factors—A Breakthrough in the Treatment of Cancer Patients with Febrile Neutropenia
by: Călin Căinap, et al.
Published: (2021-06-01) -
Validation of the CSRFENCE score for prediction of febrile neutropenia during chemotherapy cycles 2–6
by: Razan Zatarah, et al.
Published: (2022-10-01)